Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4865025
Max Phase: Preclinical
Molecular Formula: C36H40N6O6
Molecular Weight: 652.75
Molecule Type: Unknown
Associated Items:
ID: ALA4865025
Max Phase: Preclinical
Molecular Formula: C36H40N6O6
Molecular Weight: 652.75
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN1CCCNC(=O)c2cccc(c2)C(=O)NCCCN(C)CCCN2C(=O)c3ccc4c5c(ccc(c35)C2=O)C(=O)N(CCC1)C4=O
Standard InChI: InChI=1S/C36H40N6O6/c1-39-16-4-14-37-31(43)23-8-3-9-24(22-23)32(44)38-15-5-17-40(2)19-7-21-42-35(47)27-12-10-25-29-26(11-13-28(30(27)29)36(42)48)34(46)41(33(25)45)20-6-18-39/h3,8-13,22H,4-7,14-21H2,1-2H3,(H,37,43)(H,38,44)
Standard InChI Key: KNBXCBSLLBALMI-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 652.75 | Molecular Weight (Monoisotopic): 652.3009 | AlogP: 2.63 | #Rotatable Bonds: 0 |
Polar Surface Area: 139.44 | Molecular Species: BASE | HBA: 8 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 9.61 | CX LogP: 0.91 | CX LogD: -2.90 |
Aromatic Rings: 3 | Heavy Atoms: 48 | QED Weighted: 0.35 | Np Likeness Score: -0.20 |
1. Fukuda H, Sato S, Zou T, Higashi S, Takahashi O, Habu M, Sasaguri M, Tominaga K, Takenaka S, Takeuchi H.. (2021) Substituent effects of cyclic naphthalene diimide on G-quadruplex binding and the inhibition of cancer cell growth., 50 [PMID:34400300] [10.1016/j.bmcl.2021.128323] |
Source(1):